Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species

被引:32
作者
Baldi, PC
Miguel, SE
Fossati, CA
Wallach, JC
机构
[1] HOSP FJ MUNIZ,SECC BRUCELOSIS,RA-1282 BUENOS AIRES,DF,ARGENTINA
[2] CONSEJO NACL INVEST CIENT & TECN,UBA,IDEHU,INST ESTUDIOS INMUNIDAD HUMORAL,BUENOS AIRES,DF,ARGENTINA
关键词
D O I
10.1093/clinids/22.3.446
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A serological 2-year follow-up of 35 patients who had brucellosis with different clinical outcomes was performed. Patients were followed up by standard tube agglutination (STA) and 2-mercaptoethanol STA (2ME-STA) tests and by two enzyme-linked immunosorbent assays (ELISAs) to independently measure values of serum IgG to either Lipopolysaccharide (LPS) or cytoplasmic proteins of Brucella. Whereas STA and 2ME-STA tests revealed characteristic antibody profiles for patients who recovered (group I), this was not the case for patients with persistent illness (group II) or patients with relapses (group LII). On the other hand, titers measured by the 2ME-STA test were;ere low or negative in 10 patients who had positive blood cultures. Levels of IgG antibodies to LPS and proteins in each group of patients exhibited characteristic changes. For group I, however, antibodies to proteins were better predictors of recovery, since titers reached negative values for five patients. Levels of IgG antibodies to LPS and proteins were persistently high in group II patients, and peaks in these antibody levels corresponded with relapses in group III patients. The determination of values of IgG antibodies to proteins by ELISA appears useful for the serological follow-up of patients with brucellosis.
引用
收藏
页码:446 / 455
页数:10
相关论文
共 20 条
  • [1] ALTON GG, 1975, WHO MONOGRAPH SERIES, V55
  • [2] SPECIFIC ANTIBODY PROFILE IN HUMAN BRUCELLOSIS
    ARIZA, J
    PELLICER, T
    PALLARES, R
    FOZ, A
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) : 131 - 140
  • [3] BALDI PC, 1995, ACTA BIOQUIM CLIN L, V29, P147
  • [4] BUCHANAN TM, 1980, J CLIN MICROBIOL, V11, P691, DOI 10.1128/JCM.11.6.691-693.1980
  • [5] CORBEL MJ, 1983, DEV BIOL STAND, V56, P341
  • [6] CORBEL MJ, 1983, BRUCELLA PHAGES THEI
  • [7] COMPARATIVE-EVALUATION OF THE ENZYME-LINKED IMMUNOSORBENT-ASSAY IN THE LABORATORY DIAGNOSIS OF BRUCELLOSIS
    DEKLERK, E
    ANDERSON, R
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) : 381 - 386
  • [8] Diaz R., 1989, Brucellosis: Clinical and Laboratory Aspects, P73
  • [9] CHANGES IN IGM AND IGG ANTIBODY CONCENTRATIONS IN BRUCELLOSIS OVER TIME - IMPORTANCE FOR DIAGNOSIS AND FOLLOW-UP
    GAZAPO, E
    LAHOZ, JG
    SUBIZA, JL
    BAQUERO, M
    GIL, J
    DELACONCHA, EG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 219 - 225
  • [10] DIFFERENTIATION BETWEEN ACTIVE AND INACTIVE HUMAN BRUCELLOSIS BY MEASURING ANTIPROTEIN HUMORAL IMMUNE-RESPONSES
    GOLDBAUM, FA
    RUBBI, CP
    WALLACH, JC
    MIGUEL, SE
    BALDI, PC
    FOSSATI, CA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) : 604 - 607